Premium
Cirrhosis is under‐recognised in patients subsequently diagnosed with hepatocellular cancer
Author(s) -
Walker M.,
ElSerag H. B.,
Sada Y.,
Mittal S.,
Ying J.,
Duan Z.,
Richardson P.,
Davila J. A.,
Kanwal F.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13505
Subject(s) - medicine , cirrhosis , hepatocellular carcinoma , odds ratio , asymptomatic , comorbidity , alcoholic liver disease , stage (stratigraphy) , population , liver disease , veterans affairs , gastroenterology , paleontology , environmental health , biology
Summary Background Most clinical practice guidelines recommend screening for HCC in patients with cirrhosis. However, patients with compensated cirrhosis are often asymptomatic and may remain unrecognised for years. Aims To determine the extent to which cirrhosis is unrecognised in a US Veteran population with HCC , and to evaluate the association between lack of cirrhosis recognition and stage of HCC at diagnosis. Methods We reviewed the electronic medical records of a random sample of HCC cases diagnosed in the national Veterans Affairs system between 2005 and 2011. We conducted multivariable analyses adjusting for patients’ demographics, comorbidity, aetiology of underlying disease and healthcare utilisation including HCC surveillance. Results Of 1201 patients with HCC and cirrhosis, 24.6% had unrecognised cirrhosis prior to HCC diagnosis. Older patients [>65 years, odds ratio ( OR ) 2.32], African Americans ( OR 1.93), patients with alcoholic or NAFLD liver disease ( OR 1.69 and 4.77 respectively), HIV ( OR 3.02), and fewer comorbidities (Deyo 0 vs. 3, OR 2.42) had significantly higher odds of having unrecognised cirrhosis than comparison groups. Furthermore, patients with unrecognised cirrhosis were 6.5 times more likely to have advanced stage HCC at diagnosis. The effect of cirrhosis recognition on HCC stage remained significant after adjusting for pre‐specified covariates ( OR 3.37). Conclusions In one quarter of patients, cirrhosis was unrecognised prior to HCC diagnosis, and this group was significantly more likely to have advanced stage HCC . These findings emphasise the importance of timely evaluation for cirrhosis in at‐risk populations as a critical step to improving outcomes for patients with HCC.